Peer-reviewedLicence not statedDARU Journal of Pharmaceutical Sciences
Efficacy and safety of the cladribine, idarubicin, and cytarabine regimen for treating acute myeloid leukemia: a systematic review and single-arm meta-analysis
- 1School of Life Sciences and Materials Chemistry, College of Science & Technology Ningbo University, Ningbo, China
- 2The Second Clinical Medical College, Wenzhou Medical University, Wenzhou, China
Related
- The efficacy of ginger for treating chemotherapy-induced nausea and vomiting in patients with cancer: a systematic review and meta-analysis
- The efficacy and safety of adalimumab in treating axial spondyloarthritis: a systematic review and meta-analysis
- Efficacy and safety of selected Chinese herbal medicine preparations in treating carotid atherosclerosis: a systematic review and meta-analyses
- Evaluation of the clinical efficacy of endoscopic endonasal dacryocystorhinostomy in treating chronic dacryocystitis
- Efficacy, mechanisms, and influence factors of small molecule targeted therapy in treating rheumatoid arthritis: a multi-dimensional clinical, immunological, and ultrasonographic study
BibTeX
@article{xu2026efficacy,
title = {{Efficacy and safety of the cladribine, idarubicin, and cytarabine regimen for treating acute myeloid leukemia: a systematic review and single-arm meta-analysis}},
author = {Yichen Xu and Shuai Chen and Ruolin Zhang},
journal = {DARU Journal of Pharmaceutical Sciences},
year = {2026},
month = nov,
doi = {10.1007/s40199-026-00692-0},
url = {https://doi.org/10.1007/s40199-026-00692-0},
}
RIS
TY - JOUR
TI - Efficacy and safety of the cladribine, idarubicin, and cytarabine regimen for treating acute myeloid leukemia: a systematic review and single-arm meta-analysis
AU - Yichen Xu
AU - Shuai Chen
AU - Ruolin Zhang
PY - 2026
DA - 2026/11/09
JO - DARU Journal of Pharmaceutical Sciences
DO - 10.1007/s40199-026-00692-0
UR - https://doi.org/10.1007/s40199-026-00692-0
SN - 1560-8115
SN - 2008-2231
ER -